Navigation Links
HUYA Bioscience Int'l Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
Date:6/17/2008

nic arrhythmia.

Most existing marketed and development-stage anti-arrhythmics have been associated with adverse events such as Torsade de Pointes (TdP - sudden death) or appreciable QTc prolongation (a risk factor for sudden death) in Phase I or preclinical studies. As noted above, in the preclinical studies and the three Phase I studies completed in China, HBI-3000 was well tolerated.

Atrial Fibrillation (AF) is a serious type of arrhythmia found in approximately 2.2 million Americans and about 15 percent of strokes occur in people with AF(1). Ventricular Arrhythmia (VA), a severely abnormal heart rhythm, will cause death unless treated immediately. Ventricular fibrillation (VF), a type of arrhythmia, is responsible for 75 to 85 percent of sudden deaths in persons with heart problems(2).

Currently, anti-arrhythmic drugs are commonly used to treat patients with AF and VA, though in treating patients with VA, most anti-arrhythmics have failed to demonstrate a survival advantage. In some cases they may also carry safety risks, including sudden death. Pre-clinical data developed by HUYA and its Chinese partner, along with the Chinese clinical trial data are encouraging to suggest that HBI-3000 may have a useful role in the treatment of ventricular arrhythmias.

In the United States, HBI-3000 is initially being developed and investigated for use as IV treatment of atrial fibrillation with clinical trials expected to begin in early 2009. "This is a significant area of medicine for which providers need more options to treat patients," continued Gingras. "Researchers in China are developing promising compounds that would fulfill these and other unmet medical needs in the U.S. As we prepare to assemble the data and submit our IND to initiate the Phase I trials, we'll continue to leverage our collaboration and expertise in China and the U.S. It's exciting to think of the amount of time and funding that could be saved by optimizing and streamlining
'/>"/>

SOURCE HUYA Bioscience International
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
2. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
3. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
4. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
5. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
6. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
7. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
10. Neurocrine Biosciences Reports First Quarter 2008 Results
11. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned ... market share and grab a foothold in the hydroponic, hemp ... capabilities and a presence in the sector, and recently partnering ... growth of hemp and medical marijuana, iMD is committing to ...
(Date:1/23/2015)... Jan. 23, 2015   Leatt Corporation  (OTCQB: LEAT), a ... for all forms of sports, including extreme motor sports, ... announced today that the UISP Lega Motociclismo Lombardia, an ... riders to wear a neck brace during its racing ...
(Date:1/23/2015)... Ala. , Jan. 23, 2015 Gem Pharmaceuticals ... patients have been enrolled into the Company,s Phase 2 ... and safety of Gem,s lead compound, GPX-150 (an investigational ... advanced or metastatic disease. Logo - ...
Breaking Medicine Technology:iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... surgeon and clinical,instructor, Dr. Jeffery Deal, MD, FACS, ... contracting ... and dying from ... Hospital,Acquired Infections. ... quickly,spreading beyond the healthcare system into schools, gyms, ... by Dr. Deal tracked 13,510 admissions at an,accredited ...
... The first-ever human,clinical trial on a popular ... whether the tea can possibly lower the risk ... the first human safety data in a,controlled clinical ... tea is safe for the liver and kidneys,while ...
Cached Medicine Technology:Doctor Declares War on Hospital Infections, Patents MRSA-Killing Machine 2Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 2Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 3Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 4Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 5
(Date:1/22/2015)... 23, 2015 Angelweddingdress is a famous wedding ... its customers to follow it on Facebook, Twitter, and Pinterest. ... Day gift. Angelweddingdress draws a lottery every week. , Moreover, ... Feb. 28, 2015. Click Angelweddingdress homepage for more ...
(Date:1/22/2015)... 2015 The federal court overseeing thousands of ... Court, Southern District of West Virginia has upheld a $2 ... first bellwether trial. In an Order dated January 21st, the ... finding that C.R. Bard had not proven a miscarriage of ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Thousand of ... Medical Care recalled its GranuFlo and NaturaLyte dialysis concentrates ... underway in U.S. District Court, District of Massachusetts, Bernstein ... 20th, the Court has remanded a case filed by ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
(Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
... Pharmaceuticals (Nasdaq: ENDP ) announced today that it ... by its wholly owned subsidiary, BTB Purchaser Inc., for all ... Inc. (Nasdaq: IDEV ). The subsequent offering ... time on Friday, March 13, 2009. American Stock Transfer ...
... in the World Available with Levemir(R), NovoLog(R) and NovoLog(R) ... Novo Nordisk has redesigned FlexPen(R), the number one ... diabetes patients to use less force when pushing the ... insulin with prominent color branding. FlexPen(R) is only available ...
... Protection Week March 1-7, 2009 FRAMINGHAM, Mass., March 2 ... the largest increase occurring at corporations and small businesses. ... that 86 percent of data breaches could be prevented, ... Protection Program ( www.identityforce.com/MPP ) in honor of National ...
... Washington, Will Her High-Tax Tendencies Decimate The ... NEW TAXES, OBAMA ANNOUNCES SEBELIUS AS HHS ... released today by the Republican National Committee: ... President Obama Will Make A Formal Announcement ...
... Matchmaker Software Expected to Accelerate Kidney Paired Donations and ... Waiting for Kidney TransplantsPALM DESERT, Calif., March 2 ... its Kidney Paired Donation software, Silverstone Matchmaker, at the ... use by California Pacific Medical Center (CPMC - San ...
... - In discussions with lenders to restructure debt -MCLEAN, Va., ... SRZ ) today reported financial results and operating data for ... host a conference call and webcast Monday, March 2, 2009, ... , "Championing quality of life for seniors has ...
Cached Medicine News:Health News:Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals 2Health News:Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals 3Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 2Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 3Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 4Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 5Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 6Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 7Health News:New Certification Seal Identifies Merchants Committed to Fighting Identity Theft 2Health News:New Certification Seal Identifies Merchants Committed to Fighting Identity Theft 3Health News:RNC: Wrong Prescription 2Health News:RNC: Wrong Prescription 3Health News:RNC: Wrong Prescription 4Health News:RNC: Wrong Prescription 5Health News:RNC: Wrong Prescription 6Health News:Silverstone Solutions Launches New Version of Kidney Paired Donation Software at DEMO 2009 2Health News:Silverstone Solutions Launches New Version of Kidney Paired Donation Software at DEMO 2009 3Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 2Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 3Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 4Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 5Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 6Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 7Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 8Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 9Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 10Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 11Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 12Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 13Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 14Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 15Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 16Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 17Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 18Health News:Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008 19
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: